About
Clevelanddx develops proprietary diagnostics tests using solvent interaction analysis technology to improve cancer detection and reduce unnecessary biopsies, starting with its IsoPSA test for prostate cancer.
Explore Clevelanddx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.